Back to the search results

Klinikum Kassel GmbH

Mönchebergstraße 41-43
34125 Kassel

Phone: 0561-980-0
Mail: ed.lessak-mukinilk@ofni

https://www.gesundheit-nordhessen.de/klinikum-kass...

Basic information

Number of beds: 1.026
Number of specialist departments: 26

Number of inpatient cases: 47.276
Number of partial inpatient cases: 2.170
Number of outpatient cases: 98.538

Hospital owners: Klinikum Kassel GmbH
Type of provider: öffentlich

Specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law

Bezeichnung
Teilnahme externe Qualitätssicherung	yes
Bezeichnung
Teilnahme externe Qualitätssicherung	yes

External quality assurance according to the DMP

Diabetes mellitus Typ 2

Die Klinik Kinder- und Jugendmedizin nehmen am DMP Diabetes mellitus Typ II teil.

Participation in other external comparative quality assurance procedures

Implementation of the minimum quantity agreement

Treatment area

Care of premature and mature infants (with an admission weight < 1250g)

Quantity performed	50
Exception?	No exception

Complex operations on the pancreatic organ system

Quantity performed	47
Exception?	No exception

Complex interventions on the organ system esophagus for adults

Quantity performed	16
Exception?	No exception

Stem cell transplant

Quantity performed	33
Exception?	No exception

Knee joint total endoprostheses

Quantity performed	70
Exception?	No exception

Minimum quantities forecast

Care of premature and mature infants (with an admission weight < 1250g)

Overall result forecast presentation:	yes
Quantity performed reporting year:	50
Quantity forecast year:	36
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Knee joint total endoprostheses

Overall result forecast presentation:	yes
Quantity performed reporting year:	70
Quantity forecast year:	73
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Complex operations on the pancreatic organ system

Overall result forecast presentation:	yes
Quantity performed reporting year:	47
Quantity forecast year:	47
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Stem cell transplant

Overall result forecast presentation:	yes
Quantity performed reporting year:	33
Quantity forecast year:	29
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Complex interventions on the organ system esophagus for adults

Overall result forecast presentation:	yes
Quantity performed reporting year:	16
Quantity forecast year:	17
Examination by state associations?	yes
Exemption?	yes
Result of the examination by the federal state authorities?	yes
Transitional arrangement?	no

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01	Quality assurance measures for inpatient care with the indication abdominal aortic aneurysm
CQ05	Measures for quality assurance in the care of pre-term and full-term neonates – Perinatal Centre LEVEL 1
CQ25	Measures for quality assurance in the performance of minimally invasive heart valve interventions pursuant to Article 136, para. 1, sentence 1, number 2 for hospitals licensed in accordance with Article 108 of the SGB V
CQ28	Guideline on quality assurance measures for liposuction procedures for stage III lipedema (QS-RL Liposuction)
CQ02	Quality assurance measures for the inpatient care of children and adolescents with haemato-oncological diseases

Compliance with staffing requirements

Clarifying chat completed: no
Clarifying chat not completed: no
No participation in clarifying chat: no
Notification of non-fulfilment of nursing care not made: yes

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
250	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
210	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
200	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

General information

Protection concept against (sexual) violence against children and young people

According to Section 4 (2) of the Quality Management Guideline, facilities must provide for the prevention of and intervention in cases of violence and abuse as part of their internal quality management. The aim is to prevent, recognise and respond appropriately to abuse and violence, particularly against vulnerable patient groups such as children and adolescents or people in need of help, and also to prevent it within the facility. The respective procedure is aligned with the size of the facility, the range of services and the patients in order to define customised solutions for sensitising the teams as well as other suitable preventative and interventional measures. These may include information materials, contact addresses, training/education, codes of conduct, recommendations for action/intervention plans or comprehensive protection concepts.

Is a protection concept in place? Yes

Commentary on the protection concept

Gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie haben sich Einrichtungen, die Kinder und Jugendliche versorgen, gezielt mit der Prävention von und Intervention bei (sexueller) Gewalt und Missbrauch bei Kindern und Jugendlichen zu befassen (Risiko- und Gefährdungsanalyse) und – der Größe und Organisationsform der Einrichtung entsprechend – konkrete Schritte und Maßnahmen abzuleiten (Schutzkonzept). In diesem Abschnitt geben Krankenhäuser, die Kinder und Jugendliche versorgen, an, ob sie gemäß § 4 Absatz 2 in Verbindung mit Teil B Abschnitt I § 1 der Qualitätsmanagement-Richtlinie ein Schutzkonzept gegen (sexuelle) Gewalt bei Kindern und Jugendlichen aufweisen.

Drug therapy safety

Steering committee

Drug commission

Training of employees on AMTS related topics

Availability of appropriate, topic-specific informational materials for patients on AMTS e.g. for chronic diseases, for high-risk drugs, for children

Use of standardised forms for drug medical history

Arbeitsanweisung Elektronische Fallakte Medikationsverordnung

17.05.2021

Electronic support for the admission and anamnesis process (e.g. import of patient master data or medication plans, use of a drug knowledge database, input screen for drugs or anamnesis information)

Process description for an optimal medication process (e.g. drug anamnesis – prescription – patient information – drug delivery – drug application – documentation – therapy monitoring – result evaluation)

Arbeitsanweisung Elektronische Fallakte Medikationsverordnung; Sondenliste; Inkompatibilitäts-Tabelle; SOP Betäubungsmittel; etc.

17.05.2021

SOP on good prescription practices

Arbeitsanweisung Elektronische Fallakte Medikationsverordnung

17.05.2021

Possibility of electronic prescription i.e. structured entry of active substances (or name of the preparation), form, dose, dose frequency (e.g. in the HIS, in prescription software)

Provision of one or more electronic drug information systems (e.g. Lauer-Taxe®, ifap klinikCenter®, Gelbe Liste®, Fachinfo-Service®)

Concepts for ensuring the error-free preparation of medications

Zubereitung durch pharmazeutisches Personal
Anwendung von gebrauchsfertigen Arzneimitteln bzw. Zubereitungen
(Bsp: PTA auf Station, TPE Btl für F51/F52 zentral in Apotheke; KCl-Perfusoren für Intensiv zentral in Apotheke) Bereitstellen von präparatebezogenen Zubereitungshinweisen: Antiinfektivaliste, Perfusorentabelle, Versorgungsforschung mit Studie zu Flüssigkeitsrestriktion auf päd. Intensivstation, Hinterlegen fester LM und Konzentrationen in ID Diacos Pharma Karteikästen

Electronic support for the supply of patients with drugs

Vorhandensein von elektronischen Systemen zur Entscheidungsunterstützung (z.B. Meona®, Rpdoc®, AIDKlinik®, ID Medics® bzw. ID Diacos® Pharma)
CATO für Verordnung, Herstellung und teilweise Gabedokumentation von Zytostatika-Zubereitungen

Electronic documentation of the administration of drugs

Measures to minimise medication errors

Fallbesprechungen
Maßnahmen zur Vermeidung von Arzneimittelverwechslung
Spezielle AMTS-Visiten (z. B. pharmazeutische Visiten, antibiotic stewardship, Ernährung)
Teilnahme an einem einrichtungsübergreifenden Fehlermeldesystem (siehe Kapitel 12.2.3.2)
Apotheker auf Station; Apothekenvisiten; Apothekenkonsile

Measures to ensure seamless drug therapy after discharge

Aushändigung von arzneimittelbezogenen Informationen für die Weiterbehandlung und Anschlussversorgung der Patientin oder des Patienten im Rahmen eines (ggf. vorläufigen) Entlassbriefs
Aushändigung des Medikationsplans
bei Bedarf Arzneimittel-Mitgabe oder Ausstellung von Entlassrezepten

Instruments and measures

The instruments and measures to promote drug therapy safety are presented with a focus on the typical procedures of the medication process in inpatient patient care. A special feature of the medication process in the inpatient environment is the transition management during admission and discharge. The instruments and measures listed below address structural elements, e.g. special IT equipment and work materials, as well as process aspects, such as work descriptions for particularly risky process steps or concepts for securing typical risk situations . In addition, proven measures to avoid or learn from medication errors can be specified. The hospital presents here which aspects it has already dealt with and which measures it has specifically implemented. The following aspects can be presented, if necessary using free text fields:
- Admission to hospital, including anamnesis
; Instruments and measures are presented for determining the old medication (drug history), the subsequent clinical assessment and the switch to the medication available in the hospital (house list), as well as for documenting both the patient's original medication and that for hospital treatment adapted medication.
- Medication process in the hospital
In this context, the following sub-processes are assumed as examples: drug history - prescription - patient information - drug delivery - drug use - documentation - therapy monitoring - result assessment. Instruments and measures for safe medication prescription can be presented, e.g. B. in terms of readability, clarity and completeness of the documentation, but also in terms of area of application, effectiveness, benefit-risk ratio, tolerability (including potential contraindications, interactions, etc.) and resource considerations. Information can also be provided to support reliable medication ordering, delivery and use or administration.
- Discharge
In particular, the measures taken by hospitals can be presented to ensure that information on drug therapy is structured and passed on to doctors and physicians providing further treatment, as well as the appropriate provision of patients with drug information, medication plans and medications. Drug prescriptions are made.

AMTS is the totality of measures to ensure an optimal medication process with the aim of reducing medication errors and thus avoidable risks for patients during drug therapy. A prerequisite for the successful implementation of these measures is that AMTS is practised as an integral part of daily routine in an interdisciplinary and multi-professional approach.

Special instrument-based equipment

Research & teaching

Job

FL05 - Participation in multi-centre Phase I/II studies

Explanation

Mehr Informationen über die laufenden onkologischen Studien finden Sie unter "Klinikum Kassel", "Zentren", "Tumorzentrum", "Studien"

FL08 - Editors of scientific journals/textbooks

Explanation

u.a. Editorial Board: Acha und „Neuropädiatrie in Klinik und Praxis“, Mitherausgeber: Atemwegs- und Lungekrankheiten, Aktuelle Neurologie, Münchner Med. Wochenschrift. Fachzeitschrift"Kindesmisshandlung und -vernachlässigung"der DGfPI

FL04 - Project-related cooperation with colleges and universities

Explanation

u.a.: mit Frauhenhofer-Institut für Zelltherapie und Immunologie (IZI); Universität Leipzig Fakultät für Biowissenschaften, Pharmazie und Psychologie;

FL01 - Lectureships / teaching posts at colleges and universities

Explanation

Es bestehen Dozenturen/Lehrbeauftragungen u.a in der Klinik für: Lungen- und Bronchialmedizin, Neurochirurgie, Urologie, Päd. Hämatologie/Onkologie, HNO, Gastroenterologie, Frauenheilkunde/Geburtshilfe, Dermatologie, sowie an der Hamburger FU für den Bereich Pflegemanagement und Personalführung.

FL06 - Participation in multi-centre phase III/IV studies

Explanation

Mehr Informationen über die laufenden onkologischen Studien finden Sie unter "Klinikum Kassel", "Zentren", "Tumorzentrum", "Studien"

FL07 - Initiation and management of uni-centric/multi-centric clinical/scientific studies

Explanation

Mehr Informationen über die laufenden onkologischen Studien finden Sie unter "Klinikum Kassel", "Zentren", "Tumorzentrum", "Studien"

FL03 - Student training (clinical traineeship / internship year)

Explanation

Das Klinikum Kassel ist seit 2014 akademisches Lehrkrankenhaus der University Southampton (GB)

Training

Training in other healing professions

HB01 - Nurse and health care worker (m/f)

Comment

Jährlich werden 2 Ausbildungskurse angeboten. Ausbildungsstart ist jeweils zum 1. April und zum 1. Oktober. Darüber hinaus bieten wir eine Ausbildung zur Gesundheits- und Krankenpflegerin in Teilzeit an.

HB02 - Health and paediatric nurse (m/f)

Comment

Ausbildungskurse jährlich. Ausbildungsstart zum 1. Oktober.

HB10 - Midwife (m/f)

Comment

Ausbildungsstart jeweils zum 1. Oktober alle 3 Jahre (nächster Kursbeginn 2025). Die Hebammenschülerinnen können sich ab dem 2. Ausbildungsjahr im berufsbegleitendem Studiengang"Bachelor of Sience in Midwifery"einschreiben.

HB07 - Surgical technical assistant (m/f)